Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Theratechnologies Q2 Sales $22.02M Beat $21.71M Estimate, Company Ended Q2 With $36.03M In Cash

Author: Benzinga Newsdesk | July 10, 2024 07:49am
Theratechnologies (NASDAQ:THTX) reported quarterly sales of $22.02 million which beat the analyst consensus estimate of $21.71 million by 1.41 percent. This is a 25.46 percent increase over sales of $17.55 million the same period last year.

Posted In: THTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist